Heredity

News

Related Video News

No related video news stories found.

Organic Broadcast Project

Related Videos

No related videos found.

"Jumping Gene" Diminishes The Effect Of A New Type 2 Diabetes Risk Gene

Published July 4, 2009, 4:10 am, Medical News Today

Research led by the German Institute of Human Nutrition (DIfE) has identified a new gene associated with diabetes, together with a mechanism that makes obese mice less susceptible to diabetes. A genomic fragment that occurs naturally in some mouse strains diminishes the activity of the risk gene Zfp69.

Discover News | Full Story


evolutionist

Published July 4, 2009, 1:43 am, Kitchener - Waterloo Record

SANTUBONG, MALAYSIA (Jul 4, 2009) -- As he trudges past chest-high ferns and butterflies the size of saucers, George Beccaloni scours a jungle hilltop overlooking the South China Sea for signs of a long-forgotten, Victorian-era scientist.

Discover News | Full Story


'Jumping Gene' Diminishes The Effect Of New Type 2 Diabetes Risk Gene

Published July 3, 2009, 9:38 pm, Science Daily

Research has identified a new gene associated with diabetes, together with a mechanism that makes obese mice less susceptible to diabetes. A genomic fragment that occurs naturally in some mouse strains diminishes the activity of the risk gene Zfp69. The researchers also found that the corresponding human gene (ZNF642) is especially active in overweight individuals with diabetes.

Discover News | Full Story


'Jumping gene' found to diminish activity of diabetes risk gene in mice

Published July 3, 2009, 4:48 am, New Kerala

Washington, July 3: Scientists at the German Institute of Human Nutrition have announced the identification of a new gene that is associated with diabetes, and of a mechanism that makes obese mice less susceptible to diabetes.

Discover News | Full Story


'Jumping gene' diminishes the effect of a new type 2 diabetes risk gene

Published July 3, 2009, 12:03 am, PhysOrg

Research led by the German Institute of Human Nutrition (DIfE) has identified a new gene associated with diabetes, together with a mechanism that makes obese mice less susceptible to diabetes.

Discover News | Full Story


'Jumping gene' diminishes the effect of a new type 2 diabetes risk gene

Published July 2, 2009, 5:13 pm, EurekAlert!

Research has identified a new gene associated with diabetes, together with a mechanism that makes obese mice less susceptible to diabetes. A genomic fragment that occurs naturally in some mouse strains diminishes the activity of the risk gene Zfp69. The researchers also found that the corresponding human gene (ZNF642) is especially active in overweight individuals with diabetes. The results of ...

Discover News | Full Story


POZEN Submits New Drug Application For VIMOVO™ (PN 400)

Published July 2, 2009, 7:08 am, Medical News Today

POZEN Inc. (NASDAQ:POZN), announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for the marketing approval of VIMOVO™ (PN 400), the combination of enteric coated (EC) naproxen and immediate release esomeprazole. POZEN and AstraZeneca entered into a global co-development agreement for VIMOVO in August 2006.

Discover News | Full Story


Genes Are So Passé

Published July 1, 2009, 10:18 pm, GenomeWeb News

What is a " gene ?" asks Bora Zivkovic. It used to be a unit of heredity, but is it now a stretch of DNA? Or something else? A new, philosophical article in PLoS One by Evelyn Fox Keller and David Harel delves into the definition of a gene and comes up with an alternative to the concept and word of "gene."

Discover News | Full Story


Guest column: Getting rich and the marshmallow (10:11 7-1-09)

Published July 1, 2009, 7:23 am, The Danville Advocate-Messenger

The New Yorker recently published a story about the psychology of delayed gratification.

Discover News | Full Story


POZEN Submits New Drug Application For VIMOVO™ (PN 400)

Published June 30, 2009, 9:16 pm, BioresearchOnline

POZEN Inc., today announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for the marketing approval of VIMOVO (PN 400), the combination of enteric coated (EC) naproxen and immediate release esomeprazole.

Discover News | Full Story



News Directory

Get started fast by using a pre-defined news directory category

Breaking News
and Top Stories
Business
Earnings, Economy, Personal Finance, and Stock Markets
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss
Politics
Congress, Supreme Court, and White House
Science
Animals, Astronomy, Biotechnology, Space, and Weather
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis
Technology
Communications, Hardware, Internet, Personal Technology, and Software
United States
and Crimes and Trials
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East


© Copyright 2005-2006 News Meme, All Rights Reserved | More News | Link Index | OSWD Design

Powered by Odin Assemble 2.5a